Literature DB >> 11181184

The melanocortin 1 receptor is the principal mediator of the effects of agouti signaling protein on mammalian melanocytes.

Z A Abdel-Malek1, M C Scott, M Furumura, M L Lamoreux, M Ollmann, G S Barsh, V J Hearing.   

Abstract

The agouti gene codes for agouti signaling protein (ASP), which is temporally expressed in wild-type mouse follicular melanocytes where it induces pheomelanin synthesis. Studies using purified full-length agouti signaling protein has shown that it competes with (&agr;)-melanocyte stimulating hormone for binding to the melanocortin 1 receptor. We have investigated whether ASP binds exclusively to the melanocortin 1 receptor expressed on mouse melanocytes in primary culture, or additionally activates a receptor that has not been identified yet. We have compared the responses of congenic mouse melanocytes derived from C57 BL/6J-E(+)/E(+), e/e, or E(so)/E(so) mice to (alpha)-MSH and/or ASP. E(+)/E(+) melanocytes express the wild-type melanocortin 1 receptor, e/e melanocytes express a loss-of-function mutation in the melanocortin 1 receptor that results in a yellow coat color, and E(so)/E(so) is a mutation that causes constitutive activation of the melanocortin 1 receptor and renders melanocytes unresponsive to (alpha)-melanocyte stimulating hormone. Mouse E(+)/E(+) melanocytes, but not e/e or E(so)/E(so) melanocytes, respond to agouti signaling protein with decreased basal tyrosinase activity, and reduction in levels of tyrosinase and tyrosinase-related proteins 1 and 2. Only in E(+)/E(+) melanocytes does agouti signaling protein abrogate the stimulatory effects of (alpha)-melanocyte stimulating hormone on cAMP formation and tyrosinase activity. These results indicate that a functional melanocortin 1 receptor is obligatory for the response of mammalian melanocytes to agouti signaling protein.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181184     DOI: 10.1242/jcs.114.5.1019

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  15 in total

1.  Phosphorylation of BRN2 modulates its interaction with the Pax3 promoter to control melanocyte migration and proliferation.

Authors:  Irina Berlin; Laurence Denat; Anne-Lise Steunou; Isabel Puig; Delphine Champeval; Sophie Colombo; Karen Roberts; Elise Bonvin; Yveline Bourgeois; Irwin Davidson; Véronique Delmas; Laurence Nieto; Colin R Goding; Lionel Larue
Journal:  Mol Cell Biol       Date:  2012-01-30       Impact factor: 4.272

Review 2.  cAMP-mediated regulation of melanocyte genomic instability: A melanoma-preventive strategy.

Authors:  Nathaniel C Holcomb; Robert-Marlo Bautista; Stuart G Jarrett; Katharine M Carter; Madeline Krentz Gober; John A D'Orazio
Journal:  Adv Protein Chem Struct Biol       Date:  2018-12-05       Impact factor: 3.507

3.  A polymorphism in the agouti signaling protein gene is associated with human pigmentation.

Authors:  Peter A Kanetsky; Jennifer Swoyer; Saarene Panossian; Robin Holmes; DuPont Guerry; Timothy R Rebbeck
Journal:  Am J Hum Genet       Date:  2002-02-06       Impact factor: 11.025

4.  Oxidative stress level and tyrosinase activity in vitiligo patients.

Authors:  M Eskandani; J Golchai; N Pirooznia; S Hasannia
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

5.  Disruption of the RIIbeta subunit of PKA reverses the obesity syndrome of Agouti lethal yellow mice.

Authors:  Traci A Czyzyk; Maria A Sikorski; Linghai Yang; G Stanley McKnight
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-02       Impact factor: 11.205

6.  Involvement of dynein and spectrin with early melanosome transport and melanosomal protein trafficking.

Authors:  Hidenori Watabe; Julio C Valencia; Elodie Le Pape; Yuji Yamaguchi; Masayuki Nakamura; François Rouzaud; Toshihiko Hoashi; Yoko Kawa; Masako Mizoguchi; Vincent J Hearing
Journal:  J Invest Dermatol       Date:  2007-08-09       Impact factor: 8.551

7.  Mitf dosage as a primary determinant of melanocyte survival after ultraviolet irradiation.

Authors:  Thomas J Hornyak; Shunlin Jiang; Esther A Guzmán; Beth N Scissors; Chinisada Tuchinda; Hongbin He; James D Neville; Faith M Strickland
Journal:  Pigment Cell Melanoma Res       Date:  2009-02-03       Impact factor: 4.693

8.  Agouti protein, mahogunin, and attractin in pheomelanogenesis and melanoblast-like alteration of melanocytes: a cAMP-independent pathway.

Authors:  Tokimasa Hida; Kazumasa Wakamatsu; Elena V Sviderskaya; Andrew J Donkin; Lluis Montoliu; M Lynn Lamoreux; Bin Yu; Glenn L Millhauser; Shosuke Ito; Gregory S Barsh; Kowichi Jimbow; Dorothy C Bennett
Journal:  Pigment Cell Melanoma Res       Date:  2009-05-26       Impact factor: 4.693

9.  Defining MC1R regulation in human melanocytes by its agonist α-melanocortin and antagonists agouti signaling protein and β-defensin 3.

Authors:  Viki B Swope; Joshua A Jameson; Kevin L McFarland; Dorothy M Supp; William E Miller; Dennis W McGraw; Mira A Patel; Matthew A Nix; Glenn L Millhauser; George F Babcock; Zalfa A Abdel-Malek
Journal:  J Invest Dermatol       Date:  2012-05-10       Impact factor: 8.551

10.  Liver-specific expression of the agouti gene in transgenic mice promotes liver carcinogenesis in the absence of obesity and diabetes.

Authors:  Alexander I Kuklin; Randall L Mynatt; Mitchell L Klebig; Laura L Kiefer; William O Wilkison; Richard P Woychik; Edward J Michaud
Journal:  Mol Cancer       Date:  2004-06-02       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.